Showing results (121-130 of 182) with videos related to
Sort By:
Pageof 19
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 5, 2018
Evaluation of a surface plasmon resonance imaging-based multiplex O-antigen serogrouping for Escherichia coli using eleven major serotypes of Shiga -toxin-producing E. coliSatoshi Nakano, Miki Nagao, Tomomi Yamasaki, et al.Antimicrobial Agents and Chemotherapy|June 24, 2015
Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremiaYasufumi Matsumura, Masaki Yamamoto, Miki Nagao, et al.International Journal of Antimicrobial Agents|June 30, 2012
Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in JapanYasufumi Matsumura, Masaki Yamamoto, Takeshi Higuchi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 26, 2023
Increase in the frequency of community-acquired methicillin-resistant Staphylococcus aureus clones among inpatients of acute care hospitals in the Kyoto and Shiga regions, JapanMegumi Kishita, Yasufumi Matsumura, Masaki Yamamoto, et al.Nature Aging|April 28, 2023
Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccinationNorihide Jo, Yu Hidaka, Osamu Kikuchi, et al.International Journal of Hematology|November 17, 2025
Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.Lab on a Chip|January 22, 2024
SARS-CoV-2-induced disruption of a vascular bed in a microphysiological system caused by type-I interferon from bronchial organoidsKazuya Fujimoto, Yoshikazu Kameda, Yuta Nagano, et al.Cytotherapy|February 28, 2026
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.Research and Practice in Thrombosis and Haemostasis|March 4, 2026
Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcγRIIA engagementQirui Lin, Kimiko Nonomura, Ieva Stirblyte, et al.Transfusion|May 29, 2026
Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donorsTomoshige Shimizu, Tomoyasu Jo, Noriyoshi Yoshinaga, et al.Pageof 19